Sort
21,281 grants matching “influenza”
Studies on RNAi Based Delivery in Vivo
$506,503Mark A Kay · Stanford University · R01 · FY2013 · DK
Structural and functional analysis of the coronavirus spike protein fusion peptide
$506,453Gary R Whittaker · Cornell University · R01 · FY2018 · AI
Human ISG15 and USP18 Deficiencies Underlying Type I Interferonopathies
$506,430Dusan Bogunovic · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · AI
Influenza A Inhibits TH17 Host Defense Against Bacterial Pneumonia
$506,378John F Alcorn · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · HL
Influenza A Inhibits TH17 Host Defense Against Bacterial Pneumonia
$506,312John F Alcorn · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · HL
Immunologic and Predictive Features of MIS-C
$506,284Dusan Bogunovic · Columbia University Health Sciences · R01 · FY2025 · HD
P2: Defining and Visualizing Effects of Costimulation on Antiviral Immunity
$506,282Arlene H Sharpe · Harvard Medical School · P01 · FY2014 · AI
Pandemic Potential of H5N1 Influenza Viruses
$506,275Yoshihiro Kawaoka · University Of Wisconsin-Madison · R01 · FY2006 · AI
Viral Gastroenteritis: Basis of Virulence and Protection
$506,185Harry Bernard Greenberg · Palo Alto Veterans Instit For Research · R56 · FY2015 · AI
B-1 cells, IgM and Protective Humoral Immunity to Influenza
$506,091Nicole Baumgarth · Johns Hopkins University · R01 · FY2023 · AI
Development of siRNA-peptide libraries for delivery screening
$506,000Ian John Macrae · Scripps Research Institute, The · R21 · FY2025 · AI
Differentiative Signals for Macrophage Activation
$506,000Stefanie N. Vogel · University Of Maryland Baltimore · R56 · FY2015 · AI
Pathogenesis of RSV disease in the Elderly
$505,941University Of Rochester · R21 · FY2003 · AI
Immunobiology and Virology of Influenza A Virus
$505,903Jonathan W Yewdell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Leveraging Twitter to monitor nicotine and tobacco-related cancer communication
$505,649Brian A Primack · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · CA
Testing Novel Interventions to Protect Workers from Airborne Infections
$505,603Edward A. Nardell · Brigham And Women'S Hospital · R01 · FY2013 · OH
Mechanisms of regulatory T cell-mediated recovery from severe influenza A virus infection
$505,528Benjamin David Singer · Northwestern University At Chicago · R01 · FY2020 · HL
Sphingolipid signaling in age-associated vascular pathology
$505,526Timothy Tun Hla · Boston Children'S Hospital · R01 · FY2022 · AG
Sphingolipid signaling in age-associated vascular pathology
$505,526Timothy Tun Hla · Boston Children'S Hospital · R01 · FY2023 · AG
Sphingolipid signaling in age-associated vascular pathology
$505,526Timothy Tun Hla · Boston Children'S Hospital · R01 · FY2024 · AG
Development of a novel vaccine platform: Surface Antigen/Adjuvant Vaccine Engineering (SAAVE)
$505,484Michael Stephen Trent · University Of Georgia · R01 · FY2017 · AI
Role of Blimp1 (Prdm1) in lung immune responses and tolerance
$505,484Gislaine A Martins · Cedars-Sinai Medical Center · R01 · FY2022 · AI
Regulation of Follicular T cell Responses in the Lung by Ion Channels
$505,456Stefan Feske · New York University School Of Medicine · R01 · FY2017 · AI
Role of Blimp1 (Prdm1) in lung immune responses and tolerance
$505,415Gislaine A Martins · Cedars-Sinai Medical Center · R01 · FY2021 · AI
Analysis of Historical Influenza Viruses
$505,324Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI